The newspaper La Repubblica writes about a study on the application of REAC technology in patients with autism.
Introduction: The value of innovation in neurodevelopmental disorders
Autism and Autism Spectrum Disorders (ASD) require intervention strategies that go beyond symptom management, aiming at improving quality of life and functional autonomy. As evidenced by thela Repubblica article: “Autism, an Italian technology opens new perspectives in the treatment of the condition“, the integration of technology REAC (Radio Electric Asymmetric Conveyer) is offering new clinical perspectives, thanks to an approach based on the modulation of natural biological processes.
The role of REAC® Technology
REAC technology is a way of Neurobiological modulation non-invasive, designed to interact with the body’s endogenous bioelectric activity. Unlike conventional electrostimulation techniques, the REAC system is not designed to induce direct neural or muscular activation.
According to clinical evidence:
- The technology acts on fundamental physiological mechanisms rather than individual isolated symptoms.
- The treatment aims to support adaptive regulatory processes through the influence on endogenous bioelectric signalling.
- A high safety profile was observed, with treatment well tolerated by patients and free of significant adverse effects.
Clinical Implications
The application of REAC® technology in the context of neurodevelopment is based on the device’s ability to interact with the body’s regulatory networks:
- Restoration of homeostasis: The technology aims to support the restoration of adaptive homeostasis, i.e. the body’s ability to respond consistently to external and internal stimuli.
- Mechanism of Action: Instead of producing immediate analgesic or symptomatic effects, REAC Neurobiological Modulation is designed to influence the bioelectric signals involved in general physiological regulation.
- Non-invasive approach: The treatment is distinguished by its non-invasive nature, making it suitable for routine therapeutic pathways in patients with complex clinical pictures.
Conclusion
The evolution of Italian research in the field of Neurobiological Modulation opens up significant scenarios for the management of neurodevelopmental disorders. REAC technology remains a state-of-the-art tool to support natural regulation processes, offering a safe and clinically tested treatment option.
